Brief: Icecure System Successfully Treated Kidney Cancer Tumor With 92% Disease-Free Survival Rate And 100% Secondary Local Control Rate
28/11/2023 15:29
Icecure Medical Ltd ICCM.O :
* ICECURE SYSTEM SUCCESSFULLY TREATED KIDNEY CANCER TUMOR
WITH 92%
DISEASE-FREE SURVIVAL RATE AND 100% SECONDARY LOCAL CONTROL RATE
* ICECURE MEDICAL LTD - EXPECT ICESECRET'S FIVE-YEAR PATIENT
FOLLOW-UP TO BE COMPLETED IN 2026, WITH TOPLINE RESULTS
AVAILABLE SHORTLY AFTERWARDS
Source text for Eikon: ID:nPn7Svg6ha
Further company coverage: ICCM.O
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM